The NIH RECOVER Long-COVID Clinical Trials are Set to Fail: Here’s What Should be Trialed Instead
The RECOVER Initiative focused on low risk low reward clinical trials for long COVID. Here are some possibilities that could have made a real difference. .
The Paxlovid Possibility: Antiviral Drug Found Protective Against Long COVID
Veteran’s Administration Joins the Long-COVID Fray A new long-COVID preprint that recently came out just screams that times have changed. For one thing – the study is huge – 9,000 patients! It also shows long COVID has made it into the...Lives Interrupted Latest Story
Bob Graybosch
Lahaina, United States
Former occupation: Resort General Manager
$1,261,443
StudyME
Enroll in the OMF’s StudyME project and help bring about a cure for ME/CFS, fibromyalgia, POTS and long COVID.
